A Phase 1/1b Study of IAM1363 in HER2 Cancers

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-519188-17-00

Acronym

IAM1363-01

Enrollment

Registered

2025-09-11

Start date

2025-10-07

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Relapsed/refractory malignancy with documented diagnosis of human epidermal growth factor receptor 2 (HER2) alterations

None listed

Sex/Gender

All

Age

18 Years to No maximum

France, Ireland, Italy, Netherlands, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026